RB1

Information RB1

Description

The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008]

Full Name

RB transcriptional corepressor 1

Source NCBI

ReMap Statistics

Datasets
7
Biotypes
4
Peaks
111,094
Non-redundant peaks
69,524

TF Classification

Super Class
Unknown
Class
Unknown
Familly
Unknown
Sub Familly
Unknown

Source TFClass

External IDs

JASPAR
Ensembl
ENSG00000139687
UniProt
P06400
Genevisible
P06400
RefSeq
NM_000321
Aliases
OSRC; PPP1R130; RB; p105-Rb; pRb; pp110
All peaks RB1
Download BED file
Non redundant peaks RB1
Download BED file
SEQUENCES RB1
Download FASTA file
DOWNLOAD All ReMap
Got to catalogue

Datasets Table for RB1

Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks
RB1 GM12878 ENCODE Homo sapiens ENCSR785OKZ 41,597
RB1 GM12878 ENCODE Homo sapiens ENCSR916BOH 2,969
RB1 K-562 ENCODE Homo sapiens ENCSR506CVF 19,876
RB1 K-562 ENCODE Homo sapiens ENCSR670JDQ 25,380
RB1 fibroblast SENESCENT GEO Homo sapiens GSE19898 104
RB1 MCF-7 siGFP GEO Homo sapiens GSE98728 11,617
RB1 MCF-7 siH1 GEO Homo sapiens GSE98728 9,551
Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.